Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze KALV stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate KALV investment potential.

What is KALV stock price today?

Get real-time KALV stock price, historical data, and price charts on Financhill. Track KALV performance with our advanced analysis tools.

Is KALV a good investment?

Evaluate KALV investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy KALV stock?

To buy KALV stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of KALV?

View detailed market capitalization data and company valuation metrics for KALV on our comprehensive analysis page.

What is the P/E ratio of KALV?

Use our fundamental analysis tools to view KALV P/E ratio and compare valuation metrics with industry peers.

What are KALV earnings?

View KALV earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

KalVista Pharmaceuticals, Inc. 10K Form

Buy

KALV
KalVista Pharmaceuticals, Inc.

Last Price:

$16.41

Seasonality Move:

6.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KALV News And Ratings

See the #1 stock for the next 7 days that we like better than KALV

KALV Financial Statistics

Sales & Book Value

Annual Sales:	$0
Cash Flow:	$-54.8M
Price / Cash Flow:	0
Annual Sales:	$0.34
Price / Book:	43.59

Profitability

EPS (TTM):	-4.01270
Net Income (TTM):	$-210.3M
Gross Margin:	$-941K
Return on Equity:	-243.25%
Return on Assets:	-84.6%

KalVista Pharmaceuticals, Inc. Earnings Forecast

Key KalVista Pharmaceuticals, Inc. Financial Ratios

Per Share Earnings over the last 14 years have been positive in 4 years.

KalVista Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	KALV
CUSIP:	483497
Website:	kalvista.com

Debt

Debt-to-Equity Ratio:	16.62
Current Ratio:	7.22
Quick Ratio:	6.99

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

KALV Technical Analysis vs Fundamental Analysis

Buy

KalVista Pharmaceuticals, Inc. (KALV) is a Buy

Is KalVista Pharmaceuticals, Inc. a Buy or a Sell?

KalVista Pharmaceuticals, Inc. stock is rated a Buy

The current KalVista Pharmaceuticals, Inc. [KALV] share price is $14.66. The Score for KALV is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.